|
CN1953771A
|
|
Perturbed membrane-binding compounds and methods of using the same
|
|
WO2004096120A2
|
|
Compounds that selectively bind to membranes of apoptotic cells
|
|
US7270799B2
|
|
Perturbed membrane-binding compounds and methods of using the same
|
|
EP1406664A2
|
|
Targeting chemical compounds to cells
|
|
IL142051D0
|
|
Targeting of chemical compounds to apoptotic and activated cells
|
|
IL141570D0
|
|
Perturbed membrane binding compounds
|
|
IL141572D0
|
|
Microemboli binding compounds
|
|
IL141571D0
|
|
Perturbed membrane binding compounds
|
|
IL140111D0
|
|
Microemboli binding compounds
|
|
IL140113D0
|
|
Perturbed membranes binding compounds (nst800)
|
|
IL140114D0
|
|
Perturbed membranes binding compounds (nstn 700)
|
|
AU1172001A
|
|
Compounds and pharmaceutical compositions comprising same
|
|
WO0118031A2
|
|
Peptides and pharmaceutical compositions comprising same
|
|
IL137148D0
|
|
Compounds and pharmaceutical compositions comprising same and their use in the field of apoptosis or cogulation
|
|
IL132705D0
|
|
Compounds and pharmaceutical compositions comprising same
|
|
WO0010673A1
|
|
Apparatus and method for capturing particles with surface exposure of anionic phospholipids from biological fluids
|
|
IL125908D0
|
|
Peptides and pharmaceutical compositions comprising same
|
|
IL123429D0
|
|
Peptides and pharmaceutical compositions comprising same
|
